← Evidence map

ArticleNeurology. Genetics2024

Phase 1 Open-Label Study of Omigapil in Patients With LAMA2- or COL6-Related Dystrophy.

A Reghan Foley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

3 papers cite it

2024
2025
this papercites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 38915423